突变类型和脑内动脉瘤形成在自体主导多囊性脏疾病中的突变类型和脑内动脉瘤形成
Hiroshi Kataoka1,2, Hiroyuki Akagawa3, Yusuke Ushio1
1Department of Nephrology Tokyo Women's Medical University Tokyo Japan.
Stroke (Hoboken, N.J.)
|January 26, 2026
概括
自体主导多囊性病 (ADPKD) 患者的遗传突变与内动脉瘤 (IA) 的形成有关. 像拼接和框架转移突变这样的特定突变与早期的IA诊断和增加风险有关,指导向查.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 自体主导性多囊性病 (ADPKD) 患者患内动脉瘤 (IA) 的风险增加.
- 对ADPKD中IA的遗传风险因素和基因型-表型相关性尚不清楚.
- 这项研究调查了在ADPKD患者中生殖线突变和IA发展之间的关联.
研究的目的:
- 为了澄清生殖线突变与自身主导性多囊性病 (ADPKD) 患者内动脉瘤 (IAs) 的形成之间的关系.
- 确定与IA风险增加和ADPKD早期发病相关的特定遗传突变.
- 在ADPKD人群中为IA提供有针对性的查策略的信息.
主要方法:
- 一个单一中心的观察性研究包括135名ADPKD患者,他们接受了ADPKD突变的评估.
- 监测患者是否形成内动脉瘤 (IA).
- 进行了统计分析,包括多变量分析,以确定遗传突变,临床因素和IA发生之间的关联.
主要成果:
- 新的IA形成的发生率为每年1.3%的患者.
- 与替代物相比,框架转移和拼接突变与IA诊断时的年龄较小有关.
- 多变量分析确定了女性性别,家族史上的IA/下关节出血,减少估计的膜过率和拼接突变作为IA的显著风险因素. 拼接突变甚至在低风险亚组中也与IA有很强的关联,而替代物与老年患者和晚期慢性病患者的IA有关.
结论:
- 在ADPKD患者的生殖系突变分析可以帮助IA查和预后评估.
- 对于具有拼接和框架转移突变的ADPKD患者,建议对IA查.
- 针对老年ADPKD患者或具有替代突变的晚期疾病患者也应考虑针对性IA查.
相关概念视频
Mutations
94.4K
Overview
94.4K
The Ratio of X Chromosome to Autosomes
9.5K
In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female...
9.5K
Incomplete Dominance
30.0K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.0K
Chronic Kidney Disease I: Introduction
697
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
697
Chronic Kidney Disease II: Clinical Manifestations
613
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
613
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K


